VYNE Therapeutics Inc.

Historical 13F Holders

Symbol
VYNE
CUSIP
92941V308
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 34 3.93 M $1.32 M
2025 Q2 46 8.05 M $13.3 M
2025 Q1 38 7.11 M $11.4 M
2024 Q4 36 7.49 M $24.9 M
2024 Q3 35 7.67 M $14.9 M
2024 Q2 33 7.94 M $16.0 M
2024 Q1 34 7.80 M $22.8 M
2023 Q4 35 7.87 M $18.3 M
2023 Q3 21 360 k $1.45 M
2023 Q2 20 376 k $1.53 M
2023 Q1 22 336 k $1.03 M